Immuneering Corporation

What Separates Immuneering (NASDAQ:IMRX), Pharvaris (NASDAQ:PHVS) and Veraxa Biotech (NASDAQ:VRXA) as Biotechs Rise Premarket?
kalkine.ca · 21 Oct 2026
Immuneering Has Promising Survival Data, Though Its Cash Discount Needs Scrutiny (IMRX)
Seeking Alpha · 19 Oct 2026
Immuneering presents lung cancer data as Mizuho keeps Buy for Immuneering stock
AD HOC NEWS · 16 Oct 2026
Mizuho keeps Buy rating for Immuneering stock at USD 12.00
ad-hoc-news.de · 05 Oct 2026
Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
The Manila Times · 02 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.